Atlas Trials

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Clinical trial NCT00499642 · COMPLETED

Trial details

NCT number
NCT00499642
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer DiseaseHealthy
Start date
2007-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.